These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Vancomycin heteroresistance in coagulase negative Staphylococcus blood stream infections from patients of intensive care units in Mansoura University Hospitals, Egypt. Mashaly GE, El-Mahdy RH. Ann Clin Microbiol Antimicrob; 2017 Sep 19; 16(1):63. PubMed ID: 28927452 [Abstract] [Full Text] [Related]
3. In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter-related bloodstream infections from an Egyptian tertiary hospital. Hashem AA, Abd El Fadeal NM, Shehata AS. J Med Microbiol; 2017 Jun 19; 66(6):744-752. PubMed ID: 28598310 [Abstract] [Full Text] [Related]
4. The species distribution, antimicrobial resistance and risk factors for poor outcome of coagulase-negative staphylococci bacteraemia in China. Cui J, Liang Z, Mo Z, Zhang J. Antimicrob Resist Infect Control; 2019 Jun 19; 8():65. PubMed ID: 31044070 [Abstract] [Full Text] [Related]
5. Mechanisms of linezolid resistance among coagulase-negative staphylococci determined by whole-genome sequencing. Tewhey R, Gu B, Kelesidis T, Charlton C, Bobenchik A, Hindler J, Schork NJ, Humphries RM. mBio; 2014 May 13; 5(3):e00894-14. PubMed ID: 24915435 [Abstract] [Full Text] [Related]
6. Methicillin and vancomycin resistance in coagulase-negative Staphylococci isolated from the nostrils of hospitalized patients. Al-Tamimi M, Abu-Raideh J, Himsawi N, Khasawneh A, Hawamdeh H. J Infect Dev Ctries; 2020 Jan 31; 14(1):28-35. PubMed ID: 32088681 [Abstract] [Full Text] [Related]
7. Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections. Decousser JW, Desroches M, Bourgeois-Nicolaos N, Potier J, Jehl F, Lina G, Cattoir V, Vandenesh F, Doucet-Populaire F, Microbs Study Group. Int J Antimicrob Agents; 2015 Dec 31; 46(6):622-30. PubMed ID: 26453147 [Abstract] [Full Text] [Related]
11. Nosocomial coagulase-negative staphylococci in Belgrade: between Scylla and Charybdis. Protic D, Savic D, Andjelkovic D, Djukanovic N, Zdravkovic M, Djurasevic SF, Todorovic Z. J Infect Dev Ctries; 2016 Sep 30; 10(9):907-912. PubMed ID: 27694722 [Abstract] [Full Text] [Related]
12. Clinical Impact of Vancomycin MIC on Outcomes in Patients With Coagulase-negative Staphylococcal Bacteremia. Wheat W, Simiyu B, Andonie G, Bellfi L. Clin Ther; 2024 Jun 30; 46(6):444-450. PubMed ID: 38493003 [Abstract] [Full Text] [Related]
13. Nosocomial ventriculitis caused by a meticillin- and linezolid-resistant clone of Staphylococcus epidermidis in neurosurgical patients. Rodríguez-Lucas C, Fernández J, Boga JA, López-Amor L, Forcelledo L, Lázaro-López E, Rodicio MR. J Hosp Infect; 2018 Dec 30; 100(4):406-410. PubMed ID: 29458065 [Abstract] [Full Text] [Related]
17. Antibiotic susceptibility of coagulase-negative staphylococci (CoNS): emergence of teicoplanin-non-susceptible CoNS strains with inducible resistance to vancomycin. Ma XX, Wang EH, Liu Y, Luo EJ. J Med Microbiol; 2011 Nov 30; 60(Pt 11):1661-1668. PubMed ID: 21799199 [Abstract] [Full Text] [Related]
18. Efficacy of vancomycin versus linezolid against coagulase-negative staphylococci in various clinical specimens. Ehsan MM, Fatima G, Ismail MO, Memon Z. J Ayub Med Coll Abbottabad; 2014 Nov 30; 26(2):137-40. PubMed ID: 25603662 [Abstract] [Full Text] [Related]